tetano
Editor, Senior Moderator
Am J Physiol Cell Physiol
. 2023 Jul 3.
doi: 10.1152/ajpcell.00516.2022. Online ahead of print. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication
Kishore Vaddadi[SUP] 1 [/SUP], Chaitanya Gandikota[SUP] 2 [/SUP], Chaoqun Huang[SUP] 3 [/SUP], Yurong Liang[SUP] 3 [/SUP], Lin Liu[SUP] 4 [/SUP]
Affiliations
MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are implicated in viral replication and host tropism. miRNAs can impact the viruses either by directly interacting with the viral genome or modulating host factors. Although many miRNAs have predicted binding sites in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA genome, little experimental validation has been done. We first identified 492 miRNAs that have binding site(s) on the spike (S) viral RNA by a bioinformatics prediction. We then validated the selected 39 miRNAs by examining S-protein levels after co-expressing the S-protein and a miRNA into the cells. Seven miRNAs were found to reduce the S-protein levels more than 50%. Among them, miR-15a, miR-153, miR-298, miR-508, miR-1909 and miR-3130 also significantly reduced SARS-CoV-2 viral replication. SARS-CoV-2 infection decreased the expression levels of miR-298, miR-497, miR-508, miR-1909, and miR-3130, but had no significant effects on miR-15a and miR-153 levels. Intriguingly, the targeting sequences of these miRNAs on the S viral RNA showed sequence conservation among the variants of concern. Our results suggest that these miRNAs elicit effective antiviral defense against SARS-CoV-2 by modulating S-protein expression and are likely targeting all the variants. Thus, the data signifies the therapeutic potential of miRNA-based therapy for SARS-CoV-2 infections.
Keywords: SARS-CoV-2; Spike; Variants of concern; Virus replication; microRNAs.
. 2023 Jul 3.
doi: 10.1152/ajpcell.00516.2022. Online ahead of print. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication
Kishore Vaddadi[SUP] 1 [/SUP], Chaitanya Gandikota[SUP] 2 [/SUP], Chaoqun Huang[SUP] 3 [/SUP], Yurong Liang[SUP] 3 [/SUP], Lin Liu[SUP] 4 [/SUP]
Affiliations
- PMID: 37399496
- DOI: 10.1152/ajpcell.00516.2022
MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are implicated in viral replication and host tropism. miRNAs can impact the viruses either by directly interacting with the viral genome or modulating host factors. Although many miRNAs have predicted binding sites in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA genome, little experimental validation has been done. We first identified 492 miRNAs that have binding site(s) on the spike (S) viral RNA by a bioinformatics prediction. We then validated the selected 39 miRNAs by examining S-protein levels after co-expressing the S-protein and a miRNA into the cells. Seven miRNAs were found to reduce the S-protein levels more than 50%. Among them, miR-15a, miR-153, miR-298, miR-508, miR-1909 and miR-3130 also significantly reduced SARS-CoV-2 viral replication. SARS-CoV-2 infection decreased the expression levels of miR-298, miR-497, miR-508, miR-1909, and miR-3130, but had no significant effects on miR-15a and miR-153 levels. Intriguingly, the targeting sequences of these miRNAs on the S viral RNA showed sequence conservation among the variants of concern. Our results suggest that these miRNAs elicit effective antiviral defense against SARS-CoV-2 by modulating S-protein expression and are likely targeting all the variants. Thus, the data signifies the therapeutic potential of miRNA-based therapy for SARS-CoV-2 infections.
Keywords: SARS-CoV-2; Spike; Variants of concern; Virus replication; microRNAs.